Testicular Germ Cell Tumors
1 clinical trials · Condition
◉ Watch Testicular Germ Cell Tumors
| Record | Firm | Date |
|---|---|---|
| Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) (NCT06041503) | National Cancer Institute (NCI) | 2026-01-20 |
Track Testicular Germ Cell Tumors automatically
Every clearance here is in the API, with alerts when new ones post.